Additionally, PKM2 also acts as a protein kinase in the nucleus upon EGFR activation, hypoxia or glucose depletion, where it can enhance the proliferation and survival of certain types of cancer cells in response to mitogen activation or hypoxic stress [19, 21–23]. Here, EGFR is linked to cancer.